These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28506368)

  • 21. Reversible hepatic decompensation following cessation of antiretroviral therapy in a patient with HIV and hepatitis C co-infection.
    Croucher AP; Main J
    Int J STD AIDS; 2014 Sep; 25(10):762-4. PubMed ID: 24478027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management.
    Manfredi R
    AIDS; 2003 Oct; 17(15):2253-6. PubMed ID: 14523283
    [No Abstract]   [Full Text] [Related]  

  • 23. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
    Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
    Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.
    Tajima K; Kohno K; Shiono Y; Suzuki I; Kato Y; Hiroshima Y; Yamamoto M; Ohtake H; Iwaba A; Yamakawa M; Kato T
    Int J Clin Exp Pathol; 2013; 6(3):536-42. PubMed ID: 23411777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
    Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.
    Han H; Agarwal R; Martel-Laferriere V; Dieterich DT
    Clin Liver Dis; 2013 Nov; 17(4):657-70, ix. PubMed ID: 24099023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV-HCV genotype 1 coinfection.
    Lison H; Garioud A; Halfon P; Jambon S; Cordier F; Verbrigghe C; Landgraf N; Pitre C; Nguyen-Khac E; Cadranel JF
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):486-7. PubMed ID: 26934415
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection.
    Audsley J; du Cros P; Goodman Z; McLean C; Mijch A; Lewin SR; Sasadeusz J
    J Med Virol; 2012 Jul; 84(7):993-1001. PubMed ID: 22585714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)].
    Vennarecci G; Ettorre GM; Antonini M; Maritti M; Moricca P; D'Offizzi G; Narciso P; Lonardo MT; Boschetto A; Del Nonno F; Perracchio L; Palmieri GP; Visco G; Santoro E
    Tumori; 2003; 89(4 Suppl):159-61. PubMed ID: 12903579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antiretroviral HIV therapy on hepatitis B virus replication and pathogenicity.
    Gürtler LG
    Intervirology; 2014; 57(3-4):212-7. PubMed ID: 25034490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
    Carosi G; Puoti M; Antonucci G; De Luca A; Maserati R; Torti C; Bonfanti P; Bonora S; Bruno R; Gaeta GB; Antinori A; Monforte Ad; Orani A; Sagnelli E; Cargnel A; Cauda R; Mazzotta F; Pastore G; Suter F; Vullo V; ;
    AIDS Rev; 2005; 7(3):161-7. PubMed ID: 16302464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients].
    González-Colominas E; Solà R; Barrantes-González M; Salas E
    Enferm Infecc Microbiol Clin; 2013 May; 31(5):350-1. PubMed ID: 23182365
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.
    Cooper CL; Mills E; Wabwire BO; Ford N; Olupot-Olupot P
    Int J Infect Dis; 2009 May; 13(3):302-6. PubMed ID: 19004656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection].
    Rivero A; Camacho A; Pérez-Camacho I; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():45-8. PubMed ID: 20116617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data.
    Otto AO; Rivera CG; Zeuli JD; Temesgen Z
    Cells; 2021 May; 10(5):. PubMed ID: 34065305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving HCV cure rates in HIV-coinfected patients - a real-world perspective.
    Lakshmi S; Alcaide M; Palacio AM; Shaikhomer M; Alexander AL; Gill-Wiehl G; Pandey A; Patel K; Jayaweera D; Del Pilar Hernandez M
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP198-204. PubMed ID: 27266949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
    Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
    J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.